½ÃÀ庸°í¼­
»óǰÄÚµå
1762263

³ú ÀÓÇöõÆ® ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Çâ, »ê¾÷ ºÐ¼® º¸°í¼­ : Á¦Ç°º°, ¿ëµµº°, Áö¿ªº° - ½ÃÀå ¿¹Ãø(2025-2034³â)

Brain Implants Market Size, Share, Trends, Industry Analysis Report: By Product, Application, and Region - Market Forecast, 2025-2034

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Polaris Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 120 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é, ¼¼°è ³ú ÀÓÇöõÆ® ½ÃÀå ±Ô¸ð´Â 2034³â±îÁö 162¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ º¸°í¼­´Â ÇöÀç ½ÃÀå ¿ªÇп¡ ´ëÇÑ ÀÚ¼¼ÇÑ ÀλçÀÌÆ®¿Í ÇâÈÄ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

³ú ÀÓÇöõÆ®´Â ½Å°æ Ȱµ¿À» ÀÚ±Ø, °¨½Ã, Á¶Á¤Çϱâ À§ÇØ ³ú¿Í ½Å°æ°è¿¡ ¿Ü°úÀûÀ¸·Î »ðÀÔÇÏ´Â ÀÇ·á±â±âÀÔ´Ï´Ù. ÀÌ ÀÓÇöõÆ®´Â ÁÖ·Î ÆÄŲ½¼º´, °£Áú, ¸¸¼º ÅëÁõ, ¿ì¿ïÁõ°ú °°Àº ½Å°æÁúȯÀÇ Ä¡·á¿¡ »ç¿ëµË´Ï´Ù. ÀÌ ±â¼ú¿¡´Â ³ú½ÉºÎÀڱرâ, ô¼öÀڱرâ, ¹ÌÁֽŰæÀڱر⠵îÀÌ ÀÖÀ¸¸ç, °¢°¢ ƯÁ¤ ÁúȯÀ» ´ë»óÀ¸·Î ÇÕ´Ï´Ù. ³ú-ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º ¹× ¹«¼± ½Å°æ Àڱذú °°Àº ±â¼ú Çõ½ÅÀº ÀÇ·á ¹× ¿¬±¸ ºÐ¾ß¿¡¼­ ÀÌ·¯ÇÑ ÀÓÇöõÆ®ÀÇ Àû¿ë ¹üÀ§¸¦ ´õ¿í ³ÐÈ÷°í ÀÖ½À´Ï´Ù. ³ú ÀÓÇöõÆ® ½ÃÀåÀº ½Å°æ Áúȯ ȯÀÚÀÇ Áõ°¡, ½Å°æ ÀÚ±Ø Ä¡·áÀÇ Ã¤Åà Áõ°¡, ÀÓÇöõÆ® ±â¼úÀÇ ¹ßÀüÀ¸·Î ÀÎÇØ ¼ºÀåÇϰí ÀÖ½À´Ï´Ù.

À¯¸®ÇÑ ±ÔÁ¦ Á¤Ã¥, ÇコÄɾî ÅõÀÚ Áõ°¡, ÁøÇà ÁßÀÎ ÀÓ»ó½ÃÇèÀÌ ³ú ÀÓÇöõÆ® ½ÃÀåÀÇ ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀΰøÁö´É°ú ÃÖ¼Òħ½ÀÀû ½Ã¼úÀÇ ÅëÇÕÀº ÀÓÇöõÆ®¸¦ º¸´Ù È¿°úÀûÀÌ°í ½±°Ô »ç¿ëÇÒ ¼ö ÀÖµµ·Ï ÇÏ´Â ºñÁî´Ï½º ±âȸ¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù. ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ÃæÀü½Ä ¹× ÀûÀÀÇü Àڱر⠰³¹ß, Á¤½Å°Ç°­ Ä¡·á¿¡¼­ ½Å°æ ±â¼úÀÇ ¼ö¿ë È®´ë µîÀÌ ÀÖ½À´Ï´Ù. Àüü ½ÃÀåÀÇ ¼ºÀåÀº Áö¼ÓÀûÀÎ ¿¬±¸, ȯÀÚ ¼ö¿ä Áõ°¡, ÀÇ·á±â±â Á¦Á¶¾÷ü¿Í ¿¬±¸±â°üÀÇ Àü·«Àû Á¦ÈÞ¸¦ ÅëÇØ ÀÌ·ç¾îÁú °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

³ú ÀÓÇöõÆ® ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

Á¦Ç° ºÐ¾ßº°·Î´Â ½ÉºÎ³úÀڱرⰡ ÆÄŲ½¼º´ µî ¿îµ¿Àå¾Ö Ä¡·á¿¡ ³Î¸® »ç¿ëµÇ°í ÀÖ¾î 2024³â °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

Áö¿ªº°·Î´Â ºÏ¹Ì°¡ 2024³â °¡Àå Å« ³ú ÀÓÇöõÆ® ½ÃÀå Á¡À¯À²À» Â÷ÁöÇߴµ¥, ÀÌ´Â ÁַΠ÷´Ü ÀÇ·á ÀÎÇÁ¶ó¿Í ¿¬±¸°³¹ß¿¡ ´ëÇÑ ¸·´ëÇÑ ÅõÀÚ¿¡ ±âÀÎÇÕ´Ï´Ù.

³ú ÀÓÇöõÆ® ½ÃÀå ÁÖ¿ä ±â¾÷ : Abbott Laboratories, Aleva Neurotherapeutics SA, Boston Scientific Corporation, Fisher Wallace Laboratories, LLC, Functional Neuromodulation Ltd., LivaNova PLC, Medtronic plc, NDI Medical, LLC, NeuroPace, Inc., NeuroSigma, Inc., Paradromics Inc., Renishaw Plc, SceneRay Co., Ltd., Stimwave LLC, and Synchron Inc.

¸ñÂ÷

Á¦1Àå ¼Ò°³

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ¼¼°èÀÇ ³ú ÀÓÇöõÆ® ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ÇöȲ
  • ³ú ÀÓÇöõÆ® ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀΰú ±âȸ
      • ½Å°æ ±â¼ú°ú ³ú ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽ºÀÇ Áøº¸
      • ±ÔÁ¦ ´ç±¹ ½ÂÀΰú Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê
    • ¼ºÀå ¾ïÁ¦¿äÀΰú °úÁ¦
      • ¿Ü°úÀû ÀÓÇöõÆ®¿¡ µû¸¥ °íºñ¿ë°ú ¸®½ºÅ©
  • PESTEL ºÐ¼®
  • ³ú ÀÓÇöõÆ® ½ÃÀå µ¿Çâ
  • ¹ë·ùüÀÎ ºÐ¼®
  • COVID-19ÀÇ ¿µÇ⠺м®

Á¦5Àå ¼¼°èÀÇ ³ú ÀÓÇöõÆ® ½ÃÀå : Á¦Ç°º°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼Ò°³
  • ³ú½ÉºÎÀڱرâ
  • ô¼öÀڱرâ
  • ¹ÌÁֽŰæÀڱرâ

Á¦6Àå ¼¼°èÀÇ ³ú ÀÓÇöõÆ® ½ÃÀå : ¿ëµµº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼Ò°³
  • ¸¸¼º ÅëÁõ
  • °£Áú
  • ÆÄŲ½¼º´
  • ¿ì¿ïÁõ
  • º»Å¼ºÁøÀü
  • ¾ËÃ÷ÇÏÀ̸Ӻ´
  • ±âŸ

Á¦7Àå ¼¼°èÀÇ ³ú ÀÓÇöõÆ® ½ÃÀå : Áö¿ªº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼Ò°³
    • ³ú ÀÓÇöõÆ® ½ÃÀå ºÐ¼® : Áö¿ªº°, 2020-2034³â
  • ºÏ¹Ì
    • ºÏ¹Ì : Á¦Ç°º°, 2020-2034³â
    • ºÏ¹Ì : ¿ëµµº°, 2020-2034³â
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • À¯·´ : Á¦Ç°º°, 2020-2034³â
    • À¯·´ : ¿ëµµº°, 2020-2034³â
    • ¿µ±¹
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ³×´ú¶õµå
    • ·¯½Ã¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : Á¦Ç°º°, 2020-2034³â
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ¿ëµµº°, 2020-2034³â
    • Áß±¹
    • Àεµ
    • ¸»·¹À̽þÆ
    • ÀϺ»
    • Àεµ³×½Ã¾Æ
    • Çѱ¹
    • È£ÁÖ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : Á¦Ç°º°, 2020-2034³â
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ¿ëµµº°, 2020-2034³â
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • À̽º¶ó¿¤
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ¶óƾ¾Æ¸Þ¸®Ä« : Á¦Ç°º°, 2020-2034³â
    • ¶óƾ¾Æ¸Þ¸®Ä« : ¿ëµµº°, 2020-2034³â
    • ¸ß½ÃÄÚ
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«

Á¦8Àå °æÀï ±¸µµ

  • È®´ë¿Í Àμö ºÐ¼®
    • È®´ë
    • Àμö
  • Á¦ÈÞ/Çù¾÷/ÇÕÀÇ/°ø°³

Á¦9Àå ±â¾÷ °³¿ä

  • Abbott Laboratories
  • Aleva Neurotherapeutics SA
  • Boston Scientific Corporation
  • Fisher Wallace Laboratories, LLC
  • Functional Neuromodulation Ltd.
  • LivaNova PLC
  • Medtronic plc
  • NDI Medical, LLC
  • NeuroPace, Inc.
  • NeuroSigma, Inc.
ksm 25.07.09

The global brain implants market size is expected to reach USD 16.21 billion by 2034, according to a new study by Polaris Market Research. The report "Brain Implants Market Size, Share, Trends, Industry Analysis Report: By Product (Deep Brain Stimulators, Spinal Cord Stimulators, and Vagus Nerve Stimulators), Application, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Brain implants are medical devices surgically placed in the brain or nervous system to stimulate, monitor, or modulate neural activity. These implants are primarily used to treat neurological disorders such as Parkinson's disease, epilepsy, chronic pain, and depression. The technology includes deep brain stimulators, spinal cord stimulators, and vagus nerve stimulators, each targeting specific conditions. Innovations such as brain-computer interfaces and wireless neurostimulation are further enhancing the scope of these implants in both medical and research applications. The brain implants market is experiencing growth due to increasing cases of neurological disorders, rising adoption of neurostimulation therapies, and advancements in implant technology.

Favorable regulatory policies, increasing healthcare investments, and ongoing clinical trials are further supporting brain implants market expansion. Opportunities lie in the integration of artificial intelligence and minimally invasive procedures, making implants more effective and accessible. Key trends include the development of rechargeable and adaptive stimulation devices, along with the growing acceptance of neurotechnology in mental health treatments. The overall market growth is driven by continuous research, increasing patient demand, and strategic collaborations among medical device manufacturers and research institutions.

Brain Implants Market Report Highlights

By product segment, deep brain stimulators hold the largest market share in 2024 due to their widespread use in treating movement disorders such as Parkinson's disease.

By region, North America held the largest brain implants market share in 2024, primarily due to its advanced healthcare infrastructure and significant investments in research and development.

The brain implants market key players include Abbott Laboratories; Aleva Neurotherapeutics SA; Boston Scientific Corporation; Fisher Wallace Laboratories, LLC; Functional Neuromodulation Ltd.; LivaNova PLC; Medtronic plc; NDI Medical, LLC; NeuroPace, Inc.; NeuroSigma, Inc.; Paradromics Inc.; Renishaw Plc; SceneRay Co., Ltd.; Stimwave LLC; and Synchron Inc.

Polaris Market Research has segmented brain implants market report based on product, application, and region:

By Product Outlook (Revenue-USD Billion, 2020-2034)

Deep Brain Stimulators

Spinal Cord Stimulators

Vagus Nerve Stimulators

By Application Outlook (Revenue-USD Billion, 2020-2034)

Chronic Pain

Epilepsy

Parkinson's Disease

Depression

Essential Tremor

Alzheimer's Disease

Others

By Regional Outlook (Revenue-USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

Suth Korea

Indnesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

Suth Africa

Rest of Middle East & Africa

Latin America

Mexic

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Brain Implants Market Insights

  • 4.1. Brain Implants Market - Market Snapshot
  • 4.2. Brain Implants Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Advancements in Neurotechnology and Brain-Computer Interfaces
      • 4.2.1.2. Regulatory Approvals and Government Initiatives
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High costs and risks associated with surgical implantation
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Brain Implants Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Brain Implants Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Brain Implants Market, by Product, 2020-2034 (USD Billion)
  • 5.3. Deep Brain Stimulators
    • 5.3.1. Global Brain Implants Market, by Deep Brain Stimulators, by Region, 2020-2034 (USD Billion)
  • 5.4. Spinal Cord Stimulators
    • 5.4.1. Global Brain Implants Market, by Spinal Cord Stimulators, by Region, 2020-2034 (USD Billion)
  • 5.5. Vagus Nerve Stimulators
    • 5.5.1. Global Brain Implants Market, by Vagus Nerve Stimulators, by Region, 2020-2034 (USD Billion)

6. Global Brain Implants Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Brain Implants Market, by Application, 2020-2034 (USD Billion)
  • 6.3. Chronic Pain
    • 6.3.1. Global Brain Implants Market, by Chronic Pain, by Region, 2020-2034 (USD Billion)
  • 6.4. Epilepsy
    • 6.4.1. Global Brain Implants Market, by Epilepsy, by Region, 2020-2034 (USD Billion)
  • 6.5. Parkinson's Disease
    • 6.5.1. Global Brain Implants Market, by Parkinson's Disease, by Region, 2020-2034 (USD Billion)
  • 6.6. Depression
    • 6.6.1. Global Brain Implants Market, by Depression, by Region, 2020-2034 (USD Billion)
  • 6.7. Essential Tremor
    • 6.7.1. Global Brain Implants Market, by Essential Tremor, by Region, 2020-2034 (USD Billion)
  • 6.8. Alzheimer's Disease
    • 6.8.1. Global Brain Implants Market, by Alzheimer's Disease, by Region, 2020-2034 (USD Billion)
  • 6.9. Others
    • 6.9.1. Global Brain Implants Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Brain Implants Market, by Geography

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Brain Implants Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 7.3. Brain Implants Market - North America
    • 7.3.1. North America: Brain Implants Market, by Product, 2020-2034 (USD Billion)
    • 7.3.2. North America: Brain Implants Market, by Application, 2020-2034 (USD Billion)
    • 7.3.3. Brain Implants Market - U.S.
      • 7.3.3.1. U.S.: Brain Implants Market, by Product, 2020-2034 (USD Billion)
      • 7.3.3.2. U.S.: Brain Implants Market, by Application, 2020-2034 (USD Billion)
    • 7.3.4. Brain Implants Market - Canada
      • 7.3.4.1. Canada: Brain Implants Market, by Product, 2020-2034 (USD Billion)
      • 7.3.4.2. Canada: Brain Implants Market, by Application, 2020-2034 (USD Billion)
  • 7.4. Brain Implants Market - Europe
    • 7.4.1. Europe: Brain Implants Market, by Product, 2020-2034 (USD Billion)
    • 7.4.2. Europe: Brain Implants Market, by Application, 2020-2034 (USD Billion)
    • 7.4.3. Brain Implants Market - UK
      • 7.4.3.1. UK: Brain Implants Market, by Product, 2020-2034 (USD Billion)
      • 7.4.3.2. UK: Brain Implants Market, by Application, 2020-2034 (USD Billion)
    • 7.4.4. Brain Implants Market - France
      • 7.4.4.1. France: Brain Implants Market, by Product, 2020-2034 (USD Billion)
      • 7.4.4.2. France: Brain Implants Market, by Application, 2020-2034 (USD Billion)
    • 7.4.5. Brain Implants Market - Germany
      • 7.4.5.1. Germany: Brain Implants Market, by Product, 2020-2034 (USD Billion)
      • 7.4.5.2. Germany: Brain Implants Market, by Application, 2020-2034 (USD Billion)
    • 7.4.6. Brain Implants Market - Italy
      • 7.4.6.1. Italy: Brain Implants Market, by Product, 2020-2034 (USD Billion)
      • 7.4.6.2. Italy: Brain Implants Market, by Application, 2020-2034 (USD Billion)
    • 7.4.7. Brain Implants Market - Spain
      • 7.4.7.1. Spain: Brain Implants Market, by Product, 2020-2034 (USD Billion)
      • 7.4.7.2. Spain: Brain Implants Market, by Application, 2020-2034 (USD Billion)
    • 7.4.8. Brain Implants Market - Netherlands
      • 7.4.8.1. Netherlands: Brain Implants Market, by Product, 2020-2034 (USD Billion)
      • 7.4.8.2. Netherlands: Brain Implants Market, by Application, 2020-2034 (USD Billion)
    • 7.4.9. Brain Implants Market - Russia
      • 7.4.9.1. Russia: Brain Implants Market, by Product, 2020-2034 (USD Billion)
      • 7.4.9.2. Russia: Brain Implants Market, by Application, 2020-2034 (USD Billion)
    • 7.4.10. Brain Implants Market - Rest of Europe
      • 7.4.10.1. Rest of Europe: Brain Implants Market, by Product, 2020-2034 (USD Billion)
      • 7.4.10.2. Rest of Europe: Brain Implants Market, by Application, 2020-2034 (USD Billion)
  • 7.5. Brain Implants Market - Asia Pacific
    • 7.5.1. Asia Pacific: Brain Implants Market, by Product, 2020-2034 (USD Billion)
    • 7.5.2. Asia Pacific: Brain Implants Market, by Application, 2020-2034 (USD Billion)
    • 7.5.3. Brain Implants Market - China
      • 7.5.3.1. China: Brain Implants Market, by Product, 2020-2034 (USD Billion)
      • 7.5.3.2. China: Brain Implants Market, by Application, 2020-2034 (USD Billion)
    • 7.5.4. Brain Implants Market - India
      • 7.5.4.1. India: Brain Implants Market, by Product, 2020-2034 (USD Billion)
      • 7.5.4.2. India: Brain Implants Market, by Application, 2020-2034 (USD Billion)
    • 7.5.5. Brain Implants Market - Malaysia
      • 7.5.5.1. Malaysia: Brain Implants Market, by Product, 2020-2034 (USD Billion)
      • 7.5.5.2. Malaysia: Brain Implants Market, by Application, 2020-2034 (USD Billion)
    • 7.5.6. Brain Implants Market - Japan
      • 7.5.6.1. Japan: Brain Implants Market, by Product, 2020-2034 (USD Billion)
      • 7.5.6.2. Japan: Brain Implants Market, by Application, 2020-2034 (USD Billion)
    • 7.5.7. Brain Implants Market - Indonesia
      • 7.5.7.1. Indonesia: Brain Implants Market, by Product, 2020-2034 (USD Billion)
      • 7.5.7.2. Indonesia: Brain Implants Market, by Application, 2020-2034 (USD Billion)
    • 7.5.8. Brain Implants Market - South Korea
      • 7.5.8.1. South Korea: Brain Implants Market, by Product, 2020-2034 (USD Billion)
      • 7.5.8.2. South Korea: Brain Implants Market, by Application, 2020-2034 (USD Billion)
    • 7.5.9. Brain Implants Market - Australia
      • 7.5.9.1. Australia: Brain Implants Market, by Product, 2020-2034 (USD Billion)
      • 7.5.9.2. Australia: Brain Implants Market, by Application, 2020-2034 (USD Billion)
    • 7.5.10. Brain Implants Market - Rest of Asia Pacific
      • 7.5.10.1. Rest of Asia Pacific: Brain Implants Market, by Product, 2020-2034 (USD Billion)
      • 7.5.10.2. Rest of Asia Pacific: Brain Implants Market, by Application, 2020-2034 (USD Billion)
  • 7.6. Brain Implants Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Brain Implants Market, by Product, 2020-2034 (USD Billion)
    • 7.6.2. Middle East & Africa: Brain Implants Market, by Application, 2020-2034 (USD Billion)
    • 7.6.3. Brain Implants Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Brain Implants Market, by Product, 2020-2034 (USD Billion)
      • 7.6.3.2. Saudi Arabia: Brain Implants Market, by Application, 2020-2034 (USD Billion)
    • 7.6.4. Brain Implants Market - UAE
      • 7.6.4.1. UAE: Brain Implants Market, by Product, 2020-2034 (USD Billion)
      • 7.6.4.2. UAE: Brain Implants Market, by Application, 2020-2034 (USD Billion)
    • 7.6.5. Brain Implants Market - Israel
      • 7.6.5.1. Israel: Brain Implants Market, by Product, 2020-2034 (USD Billion)
      • 7.6.5.2. Israel: Brain Implants Market, by Application, 2020-2034 (USD Billion)
    • 7.6.6. Brain Implants Market - South Africa
      • 7.6.6.1. South Africa: Brain Implants Market, by Product, 2020-2034 (USD Billion)
      • 7.6.6.2. South Africa: Brain Implants Market, by Application, 2020-2034 (USD Billion)
    • 7.6.7. Brain Implants Market - Rest of Middle East & Africa
      • 7.6.7.1. Rest of Middle East & Africa: Brain Implants Market, by Product, 2020-2034 (USD Billion)
      • 7.6.7.2. Rest of Middle East & Africa: Brain Implants Market, by Application, 2020-2034 (USD Billion)
  • 7.7. Brain Implants Market - Latin America
    • 7.7.1. Latin America: Brain Implants Market, by Product, 2020-2034 (USD Billion)
    • 7.7.2. Latin America: Brain Implants Market, by Application, 2020-2034 (USD Billion)
    • 7.7.3. Brain Implants Market - Mexico
      • 7.7.3.1. Mexico: Brain Implants Market, by Product, 2020-2034 (USD Billion)
      • 7.7.3.2. Mexico: Brain Implants Market, by Application, 2020-2034 (USD Billion)
    • 7.7.4. Brain Implants Market - Brazil
      • 7.7.4.1. Brazil: Brain Implants Market, by Product, 2020-2034 (USD Billion)
      • 7.7.4.2. Brazil: Brain Implants Market, by Application, 2020-2034 (USD Billion)
    • 7.7.5. Brain Implants Market - Argentina
      • 7.7.5.1. Argentina: Brain Implants Market, by Product, 2020-2034 (USD Billion)
      • 7.7.5.2. Argentina: Brain Implants Market, by Application, 2020-2034 (USD Billion)
    • 7.7.6. Brain Implants Market - Rest of Latin America
      • 7.7.6.1. Rest of Latin America: Brain Implants Market, by Product, 2020-2034 (USD Billion)
      • 7.7.6.2. Rest of Latin America: Brain Implants Market, by Application, 2020-2034 (USD Billion)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Abbott Laboratories
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Aleva Neurotherapeutics SA
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Boston Scientific Corporation
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Fisher Wallace Laboratories, LLC
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Functional Neuromodulation Ltd.
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. LivaNova PLC
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Medtronic plc
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. NDI Medical, LLC
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. NeuroPace, Inc.
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. NeuroSigma, Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦